Regenerative medicine for spinal cord injury

In December 2021, Professor Masaya Nakamura and Professor Hideyuki Okano, both at the Keio University Hospital, successfully transplanted neural progenitors derived from induced pluripotent stem cells (iPSCs) into spinal cord injury patients (link). Treating spinal cord injury using stem cells have been extensively tested using animal models. The professors at the Keio University Hospital managed to finally apply the technology to humans.